A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food
Clinical trial NCT05337592 · COMPLETED
Trial details
- NCT number
- NCT05337592
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2022-10-18
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.